Literature DB >> 18378609

Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation.

Dawood Darbar1, Prince J Kannankeril, Brian S Donahue, Gayle Kucera, Tanya Stubblefield, Jonathan L Haines, Alfred L George, Dan M Roden.   

Abstract

BACKGROUND: Genetic studies have identified ion channel gene variants in families segregating atrial fibrillation (AF), the most common arrhythmia in clinical practice. Here, we tested the hypothesis that vulnerability to AF is associated with variation in SCN5A, the gene encoding the cardiac sodium channel. METHODS AND
RESULTS: We resequenced the entire SCN5A coding region in 375 subjects with either lone AF (n=118) or AF associated with heart disease (n=257). Controls (n=360) from the same population were then genotyped for the presence of mutations or rare variants identified in the AF cases. In 10 probands (2.7%), 8 novel variants not found in the control population (0%; P=0.001) were identified. All variants affect highly conserved residues in the SCN5A protein. In 6 families with >1 affected member, the novel variant cosegregated with AF. We also identified 11 rare missense variants in 12 probands (3.2%) that have previously been associated with inherited arrhythmia syndromes (eg, congenital long-QT syndrome and Brugada syndrome).
CONCLUSIONS: Mutations or rare variants in SCN5A may predispose patients with or without underlying heart disease to AF. The findings of the present study expand the clinical spectrum of disorders of the cardiac sodium channel to include AF and represent important progress toward molecular phenotyping and directed rather than empirical therapy for this common arrhythmia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18378609      PMCID: PMC2365761          DOI: 10.1161/CIRCULATIONAHA.107.757955

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  47 in total

Review 1.  Association study designs for complex diseases.

Authors:  L R Cardon; J I Bell
Journal:  Nat Rev Genet       Date:  2001-02       Impact factor: 53.242

Review 2.  New ideas about atrial fibrillation 50 years on.

Authors:  Stanley Nattel
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

3.  Clinical, genetic, and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block.

Authors:  Dao W Wang; Prakash C Viswanathan; Jeffrey R Balser; Alfred L George; D Woodrow Benson
Journal:  Circulation       Date:  2002-01-22       Impact factor: 29.690

4.  Nav1.5/R1193Q polymorphism is associated with both long QT and Brugada syndromes.

Authors:  H Huang; Juan Zhao; Fatima-Zahra Barrane; Jean Champagne; Mohamed Chahine
Journal:  Can J Cardiol       Date:  2006-03-15       Impact factor: 5.223

5.  Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes.

Authors:  Ping Yang; Hideaki Kanki; Benoit Drolet; Tao Yang; Jian Wei; Prakash C Viswanathan; Stefan H Hohnloser; Wataru Shimizu; Peter J Schwartz; Marshall Stanton; Katherine T Murray; Kris Norris; Alfred L George; Dan M Roden
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

6.  Locus for atrial fibrillation maps to chromosome 6q14-16.

Authors:  Patrick T Ellinor; Jordan T Shin; Rachel K Moore; Danita M Yoerger; Calum A MacRae
Journal:  Circulation       Date:  2003-06-02       Impact factor: 29.690

7.  Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation.

Authors:  Augustus O Grant; Michael P Carboni; Valentina Neplioueva; C Frank Starmer; Mirella Memmi; Carlo Napolitano; Silvia Priori
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

8.  Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome.

Authors:  Hiroshi Morita; Kengo Kusano-Fukushima; Satoshi Nagase; Yoshihisa Fujimoto; Kenichi Hisamatsu; Hideki Fujio; Kayo Haraoka; Makoto Kobayashi; Shiho Takenaka Morita; Kazufumi Nakamura; Tetsuro Emori; Hiromi Matsubara; Kazumasa Hina; Toshimasa Kita; Masahiko Fukatani; Tohru Ohe
Journal:  J Am Coll Cardiol       Date:  2002-10-16       Impact factor: 24.094

9.  KCNQ1 gain-of-function mutation in familial atrial fibrillation.

Authors:  Yi-Han Chen; Shi-Jie Xu; Said Bendahhou; Xiao-Liang Wang; Ying Wang; Wen-Yuan Xu; Hong-Wei Jin; Hao Sun; Xiao-Yan Su; Qi-Nan Zhuang; Yi-Qing Yang; Yue-Bin Li; Yi Liu; Hong-Ju Xu; Xiao-Fei Li; Ning Ma; Chun-Ping Mou; Zhu Chen; Jacques Barhanin; Wei Huang
Journal:  Science       Date:  2003-01-10       Impact factor: 47.728

10.  Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia.

Authors:  Igor Splawski; Katherine W Timothy; Michihiro Tateyama; Colleen E Clancy; Alka Malhotra; Alan H Beggs; Francesco P Cappuccio; Giuseppe A Sagnella; Robert S Kass; Mark T Keating
Journal:  Science       Date:  2002-08-23       Impact factor: 47.728

View more
  114 in total

1.  Repolarization recipes for atrial fibrillation: beyond single channel variants.

Authors:  Dawood Darbar; Babar Parvez; Robert Abraham
Journal:  J Am Coll Cardiol       Date:  2012-03-13       Impact factor: 24.094

2.  Symptomatic response to antiarrhythmic drug therapy is modulated by a common single nucleotide polymorphism in atrial fibrillation.

Authors:  Babar Parvez; Joseph Vaglio; Shane Rowan; Raafia Muhammad; Gayle Kucera; Tanya Stubblefield; Shannon Carter; Dan Roden; Dawood Darbar
Journal:  J Am Coll Cardiol       Date:  2012-06-20       Impact factor: 24.094

3.  Atrial Fibrillation in Long QT Syndrome by Genotype.

Authors:  Pyotr G Platonov; Scott McNitt; Bronislava Polonsky; Spencer Z Rosero; Wojciech Zareba
Journal:  Circ Arrhythm Electrophysiol       Date:  2019-10-15

Review 4.  Arrhythmia pharmacogenomics: methodological considerations.

Authors:  Dan M Roden; Prince J Kannankeri; Dawood Darbar
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 5.  Emerging directions in the genetics of atrial fibrillation.

Authors:  Nathan R Tucker; Patrick T Ellinor
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

6.  Atrial Fibrillation and SCN5A Variants.

Authors:  Eleonora Savio-Galimberti; Dawood Darbar
Journal:  Card Electrophysiol Clin       Date:  2014-12-01

7.  Lamin A mutation impairs interaction with nucleoporin NUP155 and disrupts nucleocytoplasmic transport in atrial fibrillation.

Authors:  Meng Han; Miao Zhao; Chen Cheng; Yuan Huang; Shengna Han; Wenjuan Li; Xin Tu; Xuan Luo; Xiaoling Yu; Yinan Liu; Qiuyun Chen; Xiang Ren; Qing Kenneth Wang; Tie Ke
Journal:  Hum Mutat       Date:  2018-12-08       Impact factor: 4.878

8.  Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation.

Authors:  Stefan Kääb; Dawood Darbar; Charlotte van Noord; Josée Dupuis; Arne Pfeufer; Christopher Newton-Cheh; Renate Schnabel; Seiko Makino; Moritz F Sinner; Prince J Kannankeril; Britt M Beckmann; Subbarao Choudry; Brian S Donahue; Jan Heeringa; Siegfried Perz; Kathryn L Lunetta; Martin G Larson; Daniel Levy; Calum A MacRae; Jeremy N Ruskin; Annette Wacker; Albert Schömig; H-Erich Wichmann; Gerhard Steinbeck; Thomas Meitinger; André G Uitterlinden; Jacqueline C M Witteman; Dan M Roden; Emelia J Benjamin; Patrick T Ellinor
Journal:  Eur Heart J       Date:  2009-01-13       Impact factor: 29.983

Review 9.  A contemporary review on the genetic basis of atrial fibrillation.

Authors:  Jason D Roberts; Michael H Gollob
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Jan-Mar

10.  Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop.

Authors:  Emelia J Benjamin; Peng-Sheng Chen; Diane E Bild; Alice M Mascette; Christine M Albert; Alvaro Alonso; Hugh Calkins; Stuart J Connolly; Anne B Curtis; Dawood Darbar; Patrick T Ellinor; Alan S Go; Nora F Goldschlager; Susan R Heckbert; José Jalife; Charles R Kerr; Daniel Levy; Donald M Lloyd-Jones; Barry M Massie; Stanley Nattel; Jeffrey E Olgin; Douglas L Packer; Sunny S Po; Teresa S M Tsang; David R Van Wagoner; Albert L Waldo; D George Wyse
Journal:  Circulation       Date:  2009-02-03       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.